Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Straus

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
Cancer Treatment Reports|May 1, 1979
Cytokinetic chemotherapy design for the treatment of advanced lung cancerM J Straus
Clinical Lymphoma|October 15, 2003
Epoetin alfa therapy for patients with hematologic malignancies and mild anemiaDavid J Straus
Therapeutic Advances in Hematology|April 5, 2013
Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patientDavid J Straus
Current Opinion in Oncology|September 1, 1993
Modern treatment approaches for Hodgkin's diseaseD J Straus
Leukemia & Lymphoma|January 1, 1995
High-risk Hodgkin's disease prognostic factorsD J Straus
Current Oncology Reports|April 11, 2001
HIV-associated lymphomasD J Straus
Lancet (London, England)|May 21, 1977
Intrathymic pathogenesis and dual genetic control of myasthenia gravisA J Straus
Journal of Pediatric Nursing|April 1, 2019
Challenges in Measuring Healthcare Transition Readiness: Taking Stock and Looking ForwardElizabeth J Straus
Current Opinion in Oncology|November 5, 1997
HIV-associated lymphomasD J Straus
Supportive Cancer Therapy|July 17, 2008
Treatment of anemia with erythropoietic agents in patients with hematologic malignanciesDavid J Straus
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
Cancer Treatment Reports|May 1, 1979
Cytokinetic chemotherapy design for the treatment of advanced lung cancerM J Straus
Clinical Lymphoma|October 15, 2003
Epoetin alfa therapy for patients with hematologic malignancies and mild anemiaDavid J Straus
Therapeutic Advances in Hematology|April 5, 2013
Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patientDavid J Straus
Current Opinion in Oncology|September 1, 1993
Modern treatment approaches for Hodgkin's diseaseD J Straus
Leukemia & Lymphoma|January 1, 1995
High-risk Hodgkin's disease prognostic factorsD J Straus
Current Oncology Reports|April 11, 2001
HIV-associated lymphomasD J Straus
Lancet (London, England)|May 21, 1977
Intrathymic pathogenesis and dual genetic control of myasthenia gravisA J Straus
Journal of Pediatric Nursing|April 1, 2019
Challenges in Measuring Healthcare Transition Readiness: Taking Stock and Looking ForwardElizabeth J Straus
Current Opinion in Oncology|November 5, 1997
HIV-associated lymphomasD J Straus
Supportive Cancer Therapy|July 17, 2008
Treatment of anemia with erythropoietic agents in patients with hematologic malignanciesDavid J Straus
Pageof 22